Christina Spaulding

1.3k total citations · 1 hit paper
16 papers, 994 citations indexed

About

Christina Spaulding is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Christina Spaulding has authored 16 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Immunology. Recurrent topics in Christina Spaulding's work include Pancreatic and Hepatic Oncology Research (5 papers), Immune Cell Function and Interaction (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Christina Spaulding is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Immune Cell Function and Interaction (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Christina Spaulding collaborates with scholars based in United States, Sweden and Slovakia. Christina Spaulding's co-authors include Barbara L. Kee, Kimberly B. Zumbrennen‐Bullough, Myles Wolf, Aline Martin, Veronica Ramirez, Jodie L. Babitt, Chia Chi Sun, Valentin David, Lixin Qi and Tamara Isakova and has published in prestigious journals such as Nature Medicine, Blood and Immunity.

In The Last Decade

Christina Spaulding

15 papers receiving 979 citations

Hit Papers

Inflammation and functional iron deficiency regulate fibr... 2015 2026 2018 2022 2015 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christina Spaulding United States 10 466 306 239 190 144 16 994
Hongwen Zhang China 16 366 0.8× 144 0.5× 72 0.3× 53 0.3× 98 0.7× 67 731
Ki‐Jo Kim South Korea 18 250 0.5× 45 0.1× 237 1.0× 64 0.3× 73 0.5× 56 1.0k
Nan Chen China 13 228 0.5× 128 0.4× 72 0.3× 115 0.6× 41 0.3× 57 624
Subba R. Chintalacharuvu United States 12 143 0.3× 152 0.5× 233 1.0× 90 0.5× 26 0.2× 17 535
Seth B. Furgeson United States 15 512 1.1× 93 0.3× 126 0.5× 69 0.4× 80 0.6× 30 953
Kayaho Maeda Japan 13 224 0.5× 105 0.3× 410 1.7× 70 0.4× 64 0.4× 29 692
Yu Wakabayashi Japan 8 303 0.7× 53 0.2× 593 2.5× 181 1.0× 63 0.4× 11 963
Xia V. Yang United States 9 244 0.5× 30 0.1× 248 1.0× 75 0.4× 79 0.5× 17 855
Kun Mu China 23 949 2.0× 77 0.3× 293 1.2× 419 2.2× 104 0.7× 59 1.6k
Fumitaka Morito Japan 15 168 0.4× 51 0.2× 270 1.1× 72 0.4× 53 0.4× 37 640

Countries citing papers authored by Christina Spaulding

Since Specialization
Citations

This map shows the geographic impact of Christina Spaulding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Spaulding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Spaulding more than expected).

Fields of papers citing papers by Christina Spaulding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina Spaulding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Spaulding. The network helps show where Christina Spaulding may publish in the future.

Co-authorship network of co-authors of Christina Spaulding

This figure shows the co-authorship network connecting the top 25 collaborators of Christina Spaulding. A scholar is included among the top collaborators of Christina Spaulding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina Spaulding. Christina Spaulding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Spaulding, Christina, Alejandra M. Marinelarena, Mario A. Shields, et al.. (2024). Targeting BCL2 with Venetoclax Enhances the Efficacy of the KRAS G12D Inhibitor MRTX1133 in Pancreatic Cancer. Cancer Research. 84(21). 3629–3639. 3 indexed citations
2.
Pham, Thao D., et al.. (2024). Trametinib Potentiates Anti-PD-1 Efficacy in Tumors Established from Chemotherapy-Primed Pancreatic Cancer Cells. Molecular Cancer Therapeutics. 23(12). 1854–1865. 1 indexed citations
3.
Shields, Mario A., Christina Spaulding, Tomonori Hirose, et al.. (2024). BET Inhibition Rescues Acinar-Ductal-Metaplasia and Ciliogenesis and Ameliorates Chronic Pancreatitis-Driven Changes in Mice With Loss of the Polarity Protein Par3. Cellular and Molecular Gastroenterology and Hepatology. 18(5). 101389–101389.
4.
Spaulding, Christina, et al.. (2024). Regorafenib induces DNA damage and enhances PARP inhibitor efficacy in pancreatic ductal carcinoma. BMC Cancer. 24(1). 1562–1562. 1 indexed citations
5.
Pham, Thao D., Christina Spaulding, Mario A. Shields, et al.. (2022). Inhibition of MNKs promotes macrophage immunosuppressive phenotype to limit CD8+ T cell antitumor immunity. JCI Insight. 7(9). 15 indexed citations
6.
Shields, Mario A., et al.. (2022). Gα13 loss in Kras/Tp53 mouse model of pancreatic tumorigenesis promotes tumors susceptible to rapamycin. Cell Reports. 38(9). 110441–110441. 6 indexed citations
7.
Pham, Thao D., Mario A. Shields, Christina Spaulding, et al.. (2021). Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies. Cancers. 13(3). 440–440. 36 indexed citations
8.
Pham, Thao D., Christina Spaulding, & Hidayatullah G. Munshi. (2020). Controlling TIME: How MNK Kinases Function to Shape Tumor Immunity. Cancers. 12(8). 2096–2096. 9 indexed citations
9.
Pham, Thao D., Mario A. Shields, Christina Spaulding, et al.. (2019). Quercetin Enhances the Anti-Tumor Effects of BET Inhibitors by Suppressing hnRNPA1. International Journal of Molecular Sciences. 20(17). 4293–4293. 48 indexed citations
10.
David, Valentin, Aline Martin, Tamara Isakova, et al.. (2015). Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney International. 89(1). 135–146. 368 indexed citations breakdown →
11.
Ramirez, Kevin, Christina Spaulding, Sasan Zandi, et al.. (2012). Gene Deregulation and Chronic Activation in Natural Killer Cells Deficient in the Transcription Factor ETS1. Immunity. 36(6). 921–932. 110 indexed citations
12.
Bhalla, Savita, et al.. (2008). Differential Roles for the E2A Activation Domains in B Lymphocytes and Macrophages. The Journal of Immunology. 180(3). 1694–1703. 22 indexed citations
13.
Spaulding, Christina, Erica J. Reschly, Yumi Yashiro–Ohtani, et al.. (2007). Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas. Blood. 110(7). 2650–2658. 40 indexed citations
14.
Reschly, Erica J., Christina Spaulding, Tomas Vilimas, et al.. (2006). Notch1 promotes survival of E2A-deficient T cell lymphomas through pre–T cell receptor–dependent and –independent mechanisms. Blood. 107(10). 4115–4121. 43 indexed citations
15.
Vilimas, Tomas, Joaquina Mascarenhas, Teresa Palomero, et al.. (2006). Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia. Nature Medicine. 13(1). 70–77. 261 indexed citations
16.
Spaulding, Christina, et al.. (2005). Nonlinear Inversion Control for a Ducted Fan UAV. AIAA Atmospheric Flight Mechanics Conference and Exhibit. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026